Share your treatment preferences for metastatic prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study asks people with metastatic prostate cancer and their doctors about what benefits and risks matter most when choosing treatment. Your answers can help improve how treatment options are discussed in Hong Kong.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You were diagnosed with metastatic prostate cancer within the last 5 years
- You can read and write
- You are willing to understand the study and sign informed consent
- You can complete the survey by yourself (physically and mentally)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study sets up a database of people with prostate cancer so researchers can learn more about patterns and outcomes. It may help your care indirectly by improving how prostate cancer is studied in Hong Kong.
This study asks people with prostate cancer to share their experiences through an online survey. The goal is to learn more about what patients go through, which may help improve future care.
This study follows people with newly diagnosed prostate cancer to understand care decisions and outcomes over the long term. It uses routine medical information and asks you to complete questionnaires, which may help improve future treatment and support.
This study looks at men with metastatic castration-resistant prostate cancer who are already taking part in the SYNGERY-201 clinical trial. The goal is to understand how treatments work and how to best support patients.
This study collects and measures “biomarkers” (measurable signs in the body) from people with prostate cancer who are about to have surgery or radiation. The goal is to understand how prostate cancer behaves during treatment, which may help improve care in the future.
This study asks men with prostate cancer about their experience preparing for and joining clinical trials. It may help improve how future trials are explained and supported for patients.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.